Welcome
FDA Advisory Committee Member a Paid Speaker for GlaxoSmithKline
August 29th, 2010
According to an article in the Wall Street Journal, one of the 33 members of a Food and Drug Administration panel to review Avandia was a paid speaker for the diabetes drug’s manufacturer, GlaxoSmithKline. Endocrinologist David Capuzzi has been paid a total…more »
Avandia prescription numbers fall after side effects warnings
August 23rd, 2010
In the wake of several studies of the health risks associated with the diabetes drug Avandia, many experts now say there are no reasons to continue prescribing Avandia when safer and equally effective alternatives are available.
more »
FDA Advisory Committee Votes to Restrict Avandia
August 17th, 2010
In July 2010, a Food and Drug Administration advisory panel voted to recommend that the agency should withdraw or severely restrict the sale of Avandia due to its potential to increase the risk of heart attacks.
more »
Avandia watchdog appointed to FDA position
October 18th, 2009
The Food and Drug Administration has appointed consumer advocate Peter Lurie as a policy advisor, signaling a shift in the agency’s regulatory approach. Prior to coming to the FDA, Lurie worked with the consumer’s group Public Citizen, where he helped…more »
Avandia users face increased heart failure, death risk, study finds
August 25th, 2009
A study by Canadian researches has revealed that patients taking the type-2 diabetes drug Avandia may be at an increased risk of heart failure or death compared with those taking another kind of diabetes drug. Scientists with the study say…more »
Avandia increased death, heart problems risk comparedto other diabetes drug
August 19th, 2009
A new study has found that patients who took Avandia were more likely to die or be hospitalized for heart problems than patients who were prescribed another diabetes drug. The study was published in the British Medical Journal and funded…more »
Study uncovers potential Avandia link to liver failure
July 25th, 2009
An analysis of adverse events reported to the Food and Drug Administration has uncovered 11 deaths due to liver toxicity among patients taking the diabetes drug Avandia. The consumers group Public Citizen, which conducted the analysis, estimates that because few…more »
Group calls on FDA to recall Avandia over liver dangers
July 25th, 2009
A leading consumer advocacy group has called on the Food and Drug Administration to recall the diabetes drug Avandia because it may cause liver failure and death. Public Citizen issued a previous call to ban Avandia in October 2008 over…more »
Study finds increased heart failure, fracture risk with Avandia
June 5th, 2009
A new study of Avandia has found that patients taking the diabetes drug had a significantly increased risk of heart failure and bone fractures. The study, known as RECORD, was presented at an annual meeting of the American Diabetes Association…more »
FDA to require stricter testing of diabetes drug after Avandia warnings
December 17th, 2008
The Food and Drug Administration has announced that it will require the manufacturers of new diabetes drugs to conduct more thorough testing to ensure that they do not increase the risk of cardiovascular problems. The agency says that the new…more »